Patent · US Active

NKp46 binding proteins

US11845795B2 · kind B2 · utility

0Cited by
19References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 8, 2019
Grant dateDec 19, 2023
Priority date—
Expiry dateNov 23, 2041

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Multispecific proteins that bind and specifically redirect NK cells to lyse a target cell of interest are provided without non-specific activation of NK cells in absence of target cells. The proteins have utility in the treatment of disease, notably cancer or infectious disease.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.